Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arrington

Showing results (631-640 of 712) with videos related to

Pageof 72
Sort By:
Journal of Neuro-Oncology|August 11, 2019
CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastasesNicholas B Figura, Thrisha K Potluri, Homan Mohammadi, et al.
Neuro-Oncology|January 29, 2022
Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastasesStephen R Lowe, Christopher P Wang, Amanda Brisco, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2012
Pyridyl aminothiazoles as potent Chk1 inhibitors: optimization of cellular activityVadim Y Dudkin, Cheng Wang, Kenneth L Arrington, et al.
The Review of Scientific Instruments|September 7, 2013
Micro-fabricated stylus ion trapChristian L Arrington, Kyle S McKay, Ehren D Baca, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2016
Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosisMark E Layton, Alexander J Reif, Timothy J Hartingh, et al.
Pigment Cell & Melanoma Research|January 10, 2020
Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directionsIsabella C Glitza, Keiran S M Smalley, Priscilla K Brastianos, et al.
Cancer Gene Therapy|November 30, 2013
Assessment of intravenous pbi-shRNA PDX1 nanoparticle (OFHIRNA-PDX1) in yucatan swineC M Jay, C Ruoff, P Kumar, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Global mapping of the <i>Chlamydia trachomatis</i> conventional secreted effector - host interactome reveals CebN interacts with nucleoporins and Rae1 to impede STAT1 nuclear translocationBrianna Steiert, Shelby E Andersen, Paige N McCaslin, et al.
American Journal of Medical Genetics. Part A|November 21, 2012
A family-based paradigm to identify candidate chromosomal regions for isolated congenital diaphragmatic herniaCammon B Arrington, Steven B Bleyl, Nori Matsunami, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2016
Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapyK A Ahmed, Y A Abuodeh, M I Echevarria, et al.
Pageof 72

Showing results (631-640 of 712) with videos related to

Sort By:
Pageof 72
Journal of Neuro-Oncology|August 11, 2019
CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastasesNicholas B Figura, Thrisha K Potluri, Homan Mohammadi, et al.
Neuro-Oncology|January 29, 2022
Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastasesStephen R Lowe, Christopher P Wang, Amanda Brisco, et al.
Bioorganic & Medicinal Chemistry Letters|February 28, 2012
Pyridyl aminothiazoles as potent Chk1 inhibitors: optimization of cellular activityVadim Y Dudkin, Cheng Wang, Kenneth L Arrington, et al.
The Review of Scientific Instruments|September 7, 2013
Micro-fabricated stylus ion trapChristian L Arrington, Kyle S McKay, Ehren D Baca, et al.
Bioorganic & Medicinal Chemistry Letters|January 27, 2016
Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosisMark E Layton, Alexander J Reif, Timothy J Hartingh, et al.
Pigment Cell & Melanoma Research|January 10, 2020
Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directionsIsabella C Glitza, Keiran S M Smalley, Priscilla K Brastianos, et al.
Cancer Gene Therapy|November 30, 2013
Assessment of intravenous pbi-shRNA PDX1 nanoparticle (OFHIRNA-PDX1) in yucatan swineC M Jay, C Ruoff, P Kumar, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Global mapping of the <i>Chlamydia trachomatis</i> conventional secreted effector - host interactome reveals CebN interacts with nucleoporins and Rae1 to impede STAT1 nuclear translocationBrianna Steiert, Shelby E Andersen, Paige N McCaslin, et al.
American Journal of Medical Genetics. Part A|November 21, 2012
A family-based paradigm to identify candidate chromosomal regions for isolated congenital diaphragmatic herniaCammon B Arrington, Steven B Bleyl, Nori Matsunami, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2016
Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapyK A Ahmed, Y A Abuodeh, M I Echevarria, et al.
Pageof 72